Alto Ingredients, Inc.
NASDAQ:ALTOChemicals - Specialty
-$0.07 today
- Market cap
- $257.92M
- Beta
- 0.14
- P/E (TTM)
- 12.5
- EPS (TTM)
- $0.39
Volume 1.03M
Average 1.92M
ALTO Sales of Investments
Cash received from selling or redeeming investments.
Alto Ingredients, Inc.NASDAQ: ALTO
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments outflow grows to $0
Q1 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $0.
Context
- Sales of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Sales of investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Sales of Investments vs competitors
How ALTO compares with its peers on the latest reported figures
- ALTO's LTM Mar 2026 sales of investments of $0 is the 3rd largest of the 7 companies compared; the peer median is $0.
- Sales of investments amounts to 0.0% of revenue for ALTO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $261M | -12.7% | +8.5% | 39.8% | |
| LTM Mar 2026 | $24.33M | — | -42.0% | 1.3% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALTO) | $0 | -12.7% | -16.7% | 0.0% | |
Competitors are the stored peer set for ALTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 46.08M | (41.6M) | (28.01M) | (58.98M) | 13.34M |
| Depreciation & Amortization | 23.29M | 25.1M | 23.08M | 24.41M | 25.22M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.88M | 3.33M | 3.9M | 4.36M | 3.02M |
| Change in Working Capital | (13.19M) | 31.55M | 3.71M | 9.96M | (16.44M) |
| Accounts Receivables | (43.55M) | 23.97M | 9.5M | 562K | 3.31M |
| Inventory | (16.45M) | (15.48M) | 11.82M | 4.48M | (12.62M) |
| Accounts Payables | 0 | 28.12B | (12.55M) | 9.95M | (2.83M) |
| Other Working Capital | 46.81M | (28.09B) | (5.05M) | (5.03M) | (4.31M) |
| Other Non-Cash Items | (32.24M) | (12.34M) | 19.35M | 16.74M | (11.89M) |
| Operating Cash Flow | 26.82M | 6.05M | 22.03M | (3.52M) | 13.25M |
| Capital Expenditures | (16.38M) | (37.74M) | (29.53M) | (11.07M) | (4.6M) |
| Acquisitions (Net) | 43.5M | (14.69M) | (3.5M) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 14.77M | 0 | (2.4M) | (2.83M) |
| Investing Cash Flow | 27.12M | (37.66M) | (33.03M) | (13.47M) | (7.43M) |
| Debt Repayment | (37.61M) | 26.78M | 12.61M | 8.99M | (15.09M) |
| Common Stock Issued | 462K | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (1.33M) | (3.67M) | 0 | 0 |
| Dividends Paid | (2.85M) | (1.27M) | (1.27M) | (1.27M) | (1.27M) |
| Other Financing Activities | 0 | (5.17M) | (714K) | 0 | 0 |
| Financing Cash Flow | (40M) | 19.01M | 6.96M | 7.72M | (16.36M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 13.94M | (12.6M) | (4.05M) | (9.27M) | (10.54M) |
| Free Cash Flow | 10.44M | (31.7M) | (7.51M) | (14.59M) | 8.65M |
Alto Ingredients, Inc.
NASDAQ:ALTO
Intrinsic Alpha fair value
Locked
Current Price
$3.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.